advanced heart failure Cardilogist . director of advance heart failure/ mechanical circulatory program. advance heart failure program developer .
New Jersey, USA
Joined March 2020
- Tweets273
- Following498
- Followers419
- Likes202
Kulpreet barn retweeted
We found that advanced heart failure and transplant cardiologists are few in number and unevenly distributed across the United States, leaving many regions with limited access to specialized care. onlinejcfi.org/article/S3050… #ACC26 @HarringtonHVI
Kulpreet barn retweeted
Congestion drives HF decompensation. Can an implantable IVC sensor safely guide care for 12 months?
In FUTURE-HF, ambulatory IVC-guided care was safe, accurate, and actionable, with improved congestion and fewer HF events. Supports a pivotal trial.
doi.org/10.1093/ejhf/xuag080
Kulpreet barn retweeted
From #pressor support to #impella support in #cardiogenicshock—how stable #pMCS enables #prehabilitation in the #ICU Gym and changes the trajectory. 💪
Kulpreet barn retweeted
⚖️ Want to review the economic value of HF therapies?
Find that here:
📖 Read the report ➡️ onlinejcf.com/article/S1071-…
📺 Watch the highlights ➡️ youtu.be/0fq_wF4IxoU
Kulpreet barn retweeted
Here are all AHFTC fellowship programs that offered spots in last 5 years, and # of fellows they matched. 13 programs trained 50% of fellows. #HFSA2025 Skewed uneven distribution. Mega centers train most of the field. Insufficient exposure to community and rural needs. Worrisome.
Kulpreet barn retweeted
🚧 The total direct costs for individuals with HF are estimated to be $227 billion in the US
HF-related costs are projected to grow significantly:
🚨 total direct medical costs for individuals with HF could rise to $858 billion by 2050
🎯 prioritize HF prevention and Rx
Just released in @JCardFail - the @HFSA HF Stats 2025 report!
📖 Read the report ➡️ onlinejcf.com/article/S1071-…
📺 Watch the highlights ➡️ youtu.be/0fq_wF4IxoU
🎯 Make these data count
👏 Special thanks to the entire writing group
#HFStats2025 #heartfailurestats
Kulpreet barn retweeted
ECMO is increasingly used a bridge to transplant. In this study of the UNOS database, use of #ECMO as a bridge to multiorgan #transplant was associated with increased 30 day mortality and decreased long-term survival @ElbertHeng @JW_MacArthur @StanfordCTSurg
🔗: jhltonline.org/article/S1053…
Kulpreet barn retweeted
3 out of 7 newly diagnosed ATTR-CM patients that I saw in 1 day didnt have ATTR-CM (2 on therapy). Just really tough to interpret PYP scans with blood pooling, and due to cavity size and shape they simply appeared as myocardial uptake to those reading them.
That is why we are running REVEAL (Evuzamitide in suspected cardiac amyloidosis). Cant afford making such mistakes.
clinicaltrials.gov/study/NCT…
#CardioTwitter #CVNuc
Kulpreet barn retweeted
🧵Substrate-based vs. clinical VT ablation?!
In ischemic VT, should we pursue substrate mapping (sinus) vs. entrainment mapping (in VT) as ablation strategy?
VT recurrence at 12 months:
👉Substrate-based ablation 15%
👉 Clinical ablation 48%
VISTA Trial ⬇️
jacc.org/doi/full/10.1016/j.…
#Epeeps
Kulpreet barn retweeted
SCD ⬇️ in HFrEF RCTs where GDMT mandated by trial protocol
In clinical practice, SCD, progressive HF☠️, and all-cause ☠️ all ⬆️ since massive gaps in use and dosing in GDMT + rising HF incidence (w/o age adjustment)
Want to save 100,000 lives a year?
Apply GDMT by protocol
Kulpreet barn retweeted
Excellent collaboration with the heart and kidney team @nyulangone to combine an LVAD implant with xeno kidney giving our patient a chance at life. Thank you to our patient and her family as well as our close collaborator
@KulpreetBarn apnews.com/article/pig-organ…
Kulpreet barn retweeted
We are pleased to inform that our DOT-HM3 Trial results in partnership between IKEM and The Brigham Harvard just got online! Our results suggest a safety signal of Apixaban use with the HM3 up to a 6-months time point in stable LVAD patients. ahajournals.org/doi/abs/10.1…
Kulpreet barn retweeted
Amazing talk by Dr. @KulpreetBarn on evolving landscape of HFpEF @ACPNJ1 24
Main takeaways:
🌟SGLT2i: Only GDMT drug in HFpEF with class 2a recommendation. Use them!
🌟Consider screening HFpEF patients for amyloid.
#DAPAHFtrial
Kulpreet barn retweeted
Excellent discussion of the AltShock-2 trial testing early IABP use in ADHF; the MYTHS trial exploring steroids in acute myocarditis; and the STEMI #DTU Trial in Milan. All three testing early interventions for @SCAI Shock A-B patients. Great to see #CSWG impacting minds globally
Kulpreet barn retweeted
New data just presented at ESC, 5 year outcomes from MOMENTUM-3. The HeartMate 3 is an excellent long-term therapy for patients living with end-stage HF with ~ 60% survival at 5 years @MRMehraMD @shelleyhallmd @preventfailure
Kulpreet barn retweeted
REVIVED showed that PCI to reduce death/HHF in LV dysfunction is dead on arrival! So, we have COURAGE, BARI-2D, FAME-2, ORBITA, & ISCHEMIA: all NEGATIVE RCTs. Let’s also add FAME-3, showing no benefit of FFR-PCI vs CABG. Evidence is overwhelming: PCI is a waste of healthcare $$. – at Quincy, MA
Kulpreet barn retweeted
COURGAE: we don’t treat these patients
ORBITA: we don’t treat these patients
ISCHEMIA: we don’t treat these patients
REVIVED: we don’t treat these patients.
Seriously?
Time to accept PCI has limited roles outside of ACS. 🤷🏽
#Cardiotwitter
Kulpreet barn retweeted
#REVIVED- #PCI for Ischaemic Ventricular Dysfunction
#ECSCongress
🫀PCI 🆚 OMT LVEF <35% ➕viability
🫀mostly men enrolled (?where are the women?)
🫀 LM disease included
🫀NO DIFFERENCE! No early difference either
@Steph_Achenbach @BiykemB @mirvatalasnag @aayshacader
Kulpreet barn retweeted
Truly amazing.
Miracle drug for the obesity epidemic?
Tirzepatide Once Weekly for the Treatment of Obesity | NEJM nejm.org/doi/full/10.1056/NE…
